IRCT20230801058996N3招募中1 期
Safety and efficacy of cell therapy with allogeneic natural killer cells activated with interleukin 2 and 15 in patients with refractory non-M3 acute myeloid leukemia (absence of hematological, morphological or molecular response after at least two treatment regimens)
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 12 years 至 80 years(—)
- 性别
- All
入选标准
- •Patients with acute myeloid leukemia(non-M3) diagnosed according to the World Health Organization classification
- •Inadequate response to induction therapy (incomplete or complete remission with minimal positive residual disease)
- •Relapse (Hematologic, morphologic or positive minimal residual disease)
- •Karnofsky index above 70%
排除标准
- •Patients with acute myeloid leukemia-M3
- •Patients with low-risk acute myeloid leukemia
- •Patients in complete molecular remission
研究者
相似试验
招募中
1 期
Evaluation of the safety and efficacy of allogeneic activated Natural killer cells in metastatic Colon AdenocarcinomaIRCT20230704058675N1Middle East Gene Therapy corporation10
已完成
1 期
Evaluation of the safety and efficacy of allogeneic hematopoietic stem cell transplantation (HSCT) using alemtuzumab for patients with aplastic anemiaAplastic anemiaJPRN-C000000356GCP-ISS HE0403 group38
已完成
1 期
Safety study of induced pluripoteint stem cell-derived cardiac spheres transplantatioJPRN-jRCTa032200189Shimizu Hideyuki3
尚未招募
不适用
Efficacy and safety of allogeneic hematopoietic cell transplantation using post-transplantation cyclophosphamide for graft-versus-host disease prophylaxis in higher-risk myelodysplastic syndrome, chronic myelomonocytic leukemia, and secondary AML patientsKCT0004151Asan Medical Center113
已完成
不适用
Safety and efficacy of allogeneic hematopoietic stem cell transplantation for refractory hematological malignancies with plerixafor-combined myeloablative conditioningacute leukemia, myelodysplastic syndrome, chronic myelogenous leukemiaJPRN-UMIN000009485Division of Hematology Keio University School of Medicine12
